Guyana vs Late-demographic dividend: Immunization, BCG
Guyana
99.0%
in 2024
Late-demographic dividend
96.6%
in 2024
Guyana rank
1st
Late-demographic dividend rank
1st
Immunization, BCG over time
- Guyana
- Late-demographic dividend
How they compare
Guyana currently reports 99.0% against 96.6% in Late-demographic dividend, a difference of 2.4%.
The two have swapped places 14 times across 45 shared years of data; in 1980 it was Guyana ahead.
Guyana ranks 1st and Late-demographic dividend ranks 1st of 165 countries.
Guyana has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Guyana | Late-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 72.7% | 56.6% | 16.1% | Guyana |
| 1990s | 90.8% | 90.7% | 0.1% | Guyana |
| 2000s | 95.1% | 92.3% | 2.8% | Guyana |
| 2010s | 97.9% | 97.6% | 0.3% | Guyana |
| 2020s | 96.2% | 95.1% | 1.1% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, bcg, Guyana or Late-demographic dividend?
- Guyana, at 99.0% against 96.6% in Late-demographic dividend as of 2024.
- What is the difference in immunization, bcg between Guyana and Late-demographic dividend?
- 2.4%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Late-demographic dividend?
- 45 years are reported by both, from 1980 to 2024.
- How do Guyana and Late-demographic dividend rank globally for immunization, bcg?
- Guyana ranks 1st and Late-demographic dividend ranks 1st of 165 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, BCG (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, BCG is the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey for BCG. A child is considered adequately immunized after one dose.